StockData
Sana Biotechnology, Inc. logo

Sana Biotechnology, Inc. (SANA) stock

SANANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$1.88+0.00 (0.00%)

Close on Nov 17, 2026Market cap $562.80MP/E –Yield –

Sana Biotechnology enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Sana Biotechnology's enterprise value was $524.92M on Nov 11, 2026, against $970.49M a year earlier. Over the last 5 years it ranged from $160.83M to $2.22B, with a median of $716.89M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$524.92M-42.3%
2025Dec 31, 2025$910.17M+465.9%
2024Dec 31, 2024$160.83M-69.7%
2023Dec 29, 2023$531.62M+109.5%
2022Dec 30, 2022$253.79M-88.6%
2021Dec 31, 2021$2.22B–

More Sana Biotechnology figures

See a number that looks wrong?